Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.28
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
1.20
Today|||52-Week Range
6.24
-22.42%
Year-to-Date

Today’s Trading

Previous close1.28
Today’s open1.31
Day’s range1.25 - 1.33
Volume560,331
Average volume (3 months)462,029
Market cap$17.9M
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
IMRNImmuron Ltd0.000.00%
DMPIDelMar Pharmaceutica...0.000.00%
EYEGEyeGate Pharmaceutic...0.000.00%
KTOVKitov Pharmaceutical...0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts